Home › Funds › CHARLES SCHWAB INVESTMENT MANAGEMENT INC › ABBV

CHARLES SCHWAB INVESTMENT MANAGEMENT INC position in ABBV

ABBVIE INC · Health Care

CHARLES SCHWAB INVESTMENT MANAGEMENT INC reported holding 13,001,868 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$3.40B, representing 0.44% of its reported portfolio and ranking #45 among its reported holdings. CHARLES SCHWAB INVESTMENT MANAGEMENT INC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)13.00M sh
Reported value held$3.40B
Portfolio Weight0.44%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How CHARLES SCHWAB INVESTMENT MANAGEMENT INC's ABBV position evolved

CHARLES SCHWAB INVESTMENT MANAGEMENT INC first disclosed a stake in ABBV in Q3 2023 at 22,749,560 shares (US$3.39B). The position peaked in Q3 2025 at 25,958,106 shares, worth US$6.01B. Across 13 filings, CHARLES SCHWAB INVESTMENT MANAGEMENT INC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 13,001,868 shares valued at US$3.40B — an increase of 87,638 shares quarter over quarter.. Notable position changes include a 48% trim in Q1 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 22.75M $3.39B New
Q4 2023 24.45M $3.77B Add
Q1 2024 22.72M $4.12B Reduce
Q2 2024 24.97M $4.28B Add
Q3 2024 23.84M $4.71B Reduce
Q4 2024 27.44M $4.88B Add
Q1 2025 25.26M $5.29B Reduce
Q2 2025 26.78M $4.97B Add
Q3 2025 25.96M $6.01B Reduce
Q4 2025 25.17M $5.75B Reduce
Q1 2026 12.97M $2.82B Reduce
Q2 2026 12.91M $3.25B Hold
Q3 2026 13.00M $3.40B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has CHARLES SCHWAB INVESTMENT MANAGEMENT INC held ABBV?

CHARLES SCHWAB INVESTMENT MANAGEMENT INC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CHARLES SCHWAB INVESTMENT MANAGEMENT INC's current position in ABBV?

As of Q3 2026, CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 13.00M shares of ABBV (ABBVIE INC), valued at $3.40B, representing 0.44% of its reported portfolio and ranking #45.

Has CHARLES SCHWAB INVESTMENT MANAGEMENT INC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), CHARLES SCHWAB INVESTMENT MANAGEMENT INC increased its position in ABBV. The position peaked in Q3 2025 at 25.96M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.